GlassScriptPhysician profile
Stella Ferker
NPI 1952650285
$3,178.75
in general payments reported to CMS, 2019-2025
12 companies · $160 in 2025
The $160 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.15 · 2021: $1,759 · 2022: $276 · 2023: $534 · 2024: $390 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,084.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,083.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,661.86 | 2021 | |
| Medtronic, INC. | $680.89 | 2021-2024 | Intellis Adaptivestim |
| Scilex Pharmaceuticals INC. | $318.35 | 2022-2025 | Ztlido |
| Si-Bone, INC. | $181.75 | 2019-2023 | |
| Spr Therapeutics, INC | $93.00 | 2025 | Sprint Pns System |
| Abbvie INC. | $54.85 | 2023 | |
| Janssen Biotech, INC. | $50.00 | 2023-2024 | Tremfya |
| Collegium Pharmaceutical, INC. | $49.22 | 2023 | Xtampza, Belbuca |
| Globus Medical, INC. | $27.86 | 2025 | Senza |
| Nevro Corp. | $25.44 | 2023 | Senza |
| Axogen | $21.61 | 2025 | |
| Vertos Medical, INC. | $13.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stella Ferker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.